ALZpath, Inc. (ALZpath), a leading developer of diagnostic tools and solutions for Alzheimer's disease and related dementias, announced the addition of Samantha Budd Haeberlein, PhD, to its board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback